| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 9 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 2 | TACROLIMUS OINTMENT 0.1% | 9 |
| 3 | PREDNISOLONE | 8 |
| 4 | PREDNISOLONE ORAL | 8 |
| 5 | PREDNISOLONE ORAL SOLUTION | 8 |
| 6 | MYCOPHENOLATE MOFETIL | 7 |
| 7 | PREDNISONE | 7 |
| 8 | TIRZEPATIDE | 6 |
| 9 | INFLIXIMAB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GARADACIMAB | 1 | 0.0013 |
| 1 | NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005% | 1 | 0.0010 |
| 2 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 3 | OSILODROSTAT | 1 | 0.0005 |
| 4 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 5 | DEUCRAVACITINIB | 1 | 0.0003 |
| 6 | CLINDAMYCIN HYDROCHLORIDE | 1 | 0.0003 |
| 7 | CROMOLYN SODIUM | 1 | 0.0003 |
| 8 | FLUOCINOLONE ACETONIDE | 1 | 0.0003 |
| 9 | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 7 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 8 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 9 | Catecholamine [EPC] | 2 | 0.0000 |